Lawson L A, Blouin R A, Parker P F
Am J Hosp Pharm. 1982 Apr;39(4):607-9.
The development and implementation of a quality assurance program for a clinical pharmacokinetic service is described. The goal of the pharmacokinetic use review program is to assure the quality and consistency of pharmacokinetic monitoring by all pharmacists within the institution. Criteria were formulated as specific indications for pharmacokinetic monitoring of four drugs. The review process consists of: (1) an initial screen of a randomly selected sample of patient charts to determine if patients meeting predetermined criteria were actually pharmacokinetically monitored; (2) a peer review committee review to specify the appropriateness of monitoring; and (3) a reporting process to the pharmacists responsible for the service regarding their performance. The quality assurance program allows documentation and improvement of the quality of a clinical pharmacokinetic service and assures a consistent level of service.
本文描述了临床药代动力学服务质量保证计划的制定与实施。药代动力学使用审查计划的目标是确保机构内所有药剂师进行的药代动力学监测的质量和一致性。制定了标准作为四种药物药代动力学监测的具体指征。审查过程包括:(1)对随机抽取的患者病历样本进行初步筛查,以确定符合预定标准的患者是否实际进行了药代动力学监测;(2)同行评审委员会审查以确定监测的适当性;以及(3)向负责该服务的药剂师报告其表现的过程。质量保证计划允许记录和提高临床药代动力学服务的质量,并确保服务水平的一致性。